Pirfenidone

Pharm Company: * APOTEX INC
Category: Lungs (Pulmonary)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Pirfenidone Overview

Pirfenidone is a medication used for the treatment of idiopathic pulmonary fibrosis. It works by reducing lung fibrosis through downregulation of the production of growth factors and procollagens I and II. It was first approved in Japan for the treatment of patients with idiopathic pulmonary fibrosis after clinical trials, under the trade name of Pirespa by Shionogi, in 2008. It was approved for use in the European Union in 2011,[2][3] in Canada in 2012, and in...

Read more Pirfenidone Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pirfenidone

Recent Pirfenidone Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Pirfenidone
  • Capsule: 267mg
  • Tablet: 267mg, 534mg, 801mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Pirfenidone or a similar ingredient: (1 result)